Wondering whether DexCom's current share price lines up with its underlying worth, or if the market is missing something important about this glucose monitoring specialist? DexCom shares last closed ...
DexCom recently reported preliminary, unaudited results showing fourth-quarter 2025 revenue of about US$1.26 billion and full-year 2025 revenue of roughly US$4.66 billion, both rising at double-digit ...
DexCom Inc. (NASDAQ:DXCM) is one of the best US stocks to buy and hold in 2026. On January 12, Barclays downgraded DexCom to Underweight from Equal Weight with a price target of $71, which was brought ...
Jake Leach, Dexcom CEO, joins 'Closing Bell Overtime' to talk its 2026 outlook, the impact of GLP-1s, new devices and more. Got a confidential news tip? We want to hear from you. Sign up for free ...
Dexcom is already working on its G8 sensor for continuous glucose monitoring (CGM). But before you get too excited, the product is still a couple of years out, CEO Jake Leach told MD+DI during the J.P ...
For the first time in a decade, DexcomDXCM has a new chief executive. And, to say Jake Leach has his work cut out for him is underselling it. Dexcom stock toppled almost 15% in 2025, pulling back ...
DexCom DXCM is facing regulatory scrutiny following a warning letter recently posted by the FDA. This could affect the approval of the company’s upcoming 15-day G7 continuous glucose monitor (CGM).
The Oura Ring 4 will cost $349 for Silver or Black, $399 for Brushed Silver or Stealth, or $499 for Gold or Rose Gold. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results